Bis(1H-imidazole);1,2,4-oxadiazole;1,3,4-oxadiazole;1,3-oxazole;1H-pyrazole;1H-pyrrole;1,3-thiazole
C23H27N13O3S — CID 157469824
Data last refreshed: (MolForge compound catalog, from PubChem)
About Bis(1H-imidazole);1,2,4-oxadiazole;1,3,4-oxadiazole;1,3-oxazole;1H-pyrazole;1H-pyrrole;1,3-thiazole
Bis(1H-imidazole);1,2,4-oxadiazole;1,3,4-oxadiazole;1,3-oxazole;1H-pyrazole;1H-pyrrole;1,3-thiazole (PubChem CID 157469824) has the molecular formula C23H27N13O3S and a molecular weight of 565.62 g/mol. Its IUPAC name is bis(1H-imidazole);1,2,4-oxadiazole;1,3,4-oxadiazole;1,3-oxazole;1H-pyrazole;1H-pyrrole;1,3-thiazole.
Molecular Properties
| Compound Name | Bis(1H-imidazole);1,2,4-oxadiazole;1,3,4-oxadiazole;1,3-oxazole;1H-pyrazole;1H-pyrrole;1,3-thiazole |
|---|---|
| PubChem CID | 157469824 |
| Molecular Formula | C23H27N13O3S |
| Molecular Weight | 565.62 g/mol |
| Exact Mass | 565.21 |
| IUPAC Name | bis(1H-imidazole);1,2,4-oxadiazole;1,3,4-oxadiazole;1,3-oxazole;1H-pyrazole;1H-pyrrole;1,3-thiazole |
| SMILES | c1c[nH]cn1.c1c[nH]cn1.c1cc[nH]c1.c1cn[nH]c1.c1cocn1.c1cscn1.c1ncon1.c1nnco1 |
| InChI | InChI=1S/C4H5N.3C3H4N2.C3H3NO.C3H3NS.2C2H2N2O/c1-2-4-5-3-1;2*1-2-5-3-4-1;1-2-4-5-3-1;2*1-2-5-3-4-1;1-3-4-2-5-1;1-3-2-5-4-1/h1-5H;3*1-3H,(H,4,5);2*1-3H;2*1-2H |
| InChIKey | BUXBRLQIVHXPOE-UHFFFAOYSA-N |
| XLogP | 4.20 |
| TPSA | 218.59 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 13 |
| Rotatable Bonds | |
| Heavy Atoms | 40 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 565.62 |
| LogP ≤ 5 | 4.20 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 13 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157469824 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.